HIV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission

Journal of Infectious Diseases

Volumn 199, Issue 6, 2009, Pages 889-898

  John Stewart, Grace C ^a,b,e   Mbori Ngacha, Dorothy ^a   Payne, Barbara Lohman ^a,b   Farquhar, Carey ^b   Richardson, Barbra A ^b,c   Emery, Sandra ^c   Otieno, Phelgona ^a   Obimbo, Elizabeth ^a   Dong, Tao ^d   Slyker, Jennifer ^d   Nduati, Ruth ^a   Overbaugh, Julie ^c   Rowland Jones, Sarah ^d  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Box 359909 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS TRANSMISSION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TRANSMISSION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERFERON-GAMMA; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 65649127179     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597120     Document Type: Article

References (35)

1. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000; 283:1167-74.
2. Rowland-Jones SL, Nixon DF, Aldhous MC, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993; 341:860-1.
3. Legrand FA, Nixon DF, Loo CP, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 2006; 1:e102.
4. Cheynier R, Langlade-Demoyen P, Marescot MR, et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992; 22: 2211-7.
5. Wasik TJ, Bratosiewicz J, Wierzbicki A, et al. Protective role of betachemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 1999; 162:4355-64.
6. Rowland-Jones S, Tan R, McMichael A. Role of cellular immunity in protection against HIV infection. Adv Immunol 1997; 65:277-346.
7. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002; 415:335-9.
8. Kaul R, Rowland-Jones SL, Kimani J, et al. Late seroconversion in HIVresistant Nairobi prostitutes despite pre-existing HIV-specific CD8- responses. J Clin Invest 2001; 107:341-9.
9. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8-T-cell responses containing replication of the primary virus. Nature 2002; 420:434-9.
10. STEP study: disappointing, but not a failure. Lancet 2007; 370:1665.
11. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999; 353:773-80.
12. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCRSSP). Tissue Antigens 1995; 46:355-67.
13. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8-memory T cells. J Exp Med 1997; 186: 859-65.
14. Lohman BL, Slyker JA, Richardson BA, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol 2005; 79:8121-30.
15. Slyker JA, Lohman BL, Mbori-Ngacha DA, et al. Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants. Vaccine 2005; 23:4711-9.
16. Schmechel SC, Russell N, Hladik F, et al. Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons. Immunol Lett 2001; 79:21-7.
17. Russell ND, Hudgens MG, Ha R, Havenar-Daughton C, McElrath MJ. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J Infect Dis 2003; 187:226-42.
18. Panteleeff DD, John G, Nduati R, et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999; 37:350-3.
19. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994; 170:1296-9.
20. ChunTW,Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183-8.
21. Sacha JB, Chung C, Rakasz EG, et al. Gag-specific CD8-T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J Immunol 2007; 178:2746-54.
22. Miller CJ, Marthas M, Torten J, et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 1994; 68:6391-400.
23. MacGregor RR, Ginsberg R, Ugen KE, et al. T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. AIDS 2002; 16:2137-43.
24. Mwau M, Cebere I, Sutton J, et al. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol 2004; 85:911-9.
25. Buseyne F, Burgard M, Teglas JP, et al. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. AIDS Res Hum Retroviruses 1998; 14:1435-44.
26. Luzuriaga K, Holmes D, Hereema A, Wong J, Panicali DL, Sullivan JL. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol 1995; 154:433-43.
27. Bernard NF, Yannakis CM, Lee JS, Tsoukas CM. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J Infect Dis 1999; 179:538 - 47.
28. Tobery TW, Dubey SA, Anderson K, et al. A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV type 1 gag vaccinated human subjects. AIDS Res Hum Retroviruses 2006; 22:1081-90.
29. Coplan PM, Gupta SB, Dubey SA, et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005; 191:1427-34.
30. Kaul R, Dong T, Plummer FA, et al. CD8- lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001; 107:1303-10.
31. Beattie T, Kaul R, Rostron T, et al. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. AIDS 2004; 18:1595-8.
32. Graham BS, Koup RA, Roederer M, et al. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J Infect Dis 2006; 194:1650-60.
33. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic- T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl JMed 1997; 337:1267-74.
34. Dyer WB, Ogg GS, Demoitie MA, et al. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol 1999; 73:436-43.
35. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3:212-7.